Heal Capital

Founded in Berlin, Germany in 2019, Heal Capital is a venture capital firm focused on investing in the healthcare and technology sectors. It manages one of Europe's leading dedicated investment funds for HealthTech, with over EUR 200 million in total investment volume. The fund backs mission-driven founders at pre-seed to Series A stages, providing capital and HealthTech-specific expertise to accelerate market access within the healthcare system.

Hana Besbes

Venture Partner

Ivana Jelic

Venture Partner

Eckhardt Weber

Founding Managing Partner

Christian Weiss Ph.D

Venture Partner

Peter Wibbe

Founding Partner

29 past transactions

CGC Genomics

Pre Seed Round in 2025
At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10 million patients with metastatic cancer.​ Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed.

Hema.to

Seed Round in 2025
Hema.to specializes in AI-powered blood cancer detection software. It automates the analysis of flow cytometry data, enhancing lab efficiency and accuracy.

Apheris

Series A in 2025
Apheris specializes in secure data sharing for machine learning. Its platform enables businesses to collaboratively analyze distributed datasets without transferring sensitive information, ensuring compliance with privacy regulations.

Heim Health

Seed Round in 2024
Heim Health is a healthcare firm using technology to deliver scalable, community-based solutions.

Paloma Health

Pre Seed Round in 2024
A technology-enabled provider of children's mental health services, starting with autism assessments.

Parto

Pre Seed Round in 2024
Parto services include business accounts, accounts with fiduciary custody, and payment cards for staff members and those receiving care. Using our proprietary software, which allows for automated billing of business expenses and digital custody fund administration.

Gleamer

Series B in 2023
Gleamer develops AI-powered radiology software that acts as an automated second reader within clinicians' standard imaging workflows. Its AI companions automatically detect bone abnormalities and lesions on X-ray exams, highlighting findings and providing preliminary data to support diagnoses, speeding interpretation and helping radiologists prioritize patients. The tools integrate into routine reading environments and are deployed across multiple countries and institutions to improve diagnostic accuracy and efficiency in trauma and general radiography.

Hema.to

Seed Round in 2023
Hema.to specializes in AI-powered blood cancer detection software. It automates the analysis of flow cytometry data, enhancing lab efficiency and accuracy.

Sanvivo

Seed Round in 2023
Sanvivo develops a digital pharmacy network that connects pharmacies with various platforms, online shops, delivery services, and prescription apps. Its intuitive software integrates with existing inventory management systems, allowing pharmacies to efficiently handle orders from multiple sources, expanding customer reach and sales.

Medicilio - Cantieri Digitali Medtech

Seed Round in 2023
At Cantieri Digitali Medtech, we launch innovative ventures in medical technology. With our experience in home medicine, software development, operations and seamless user experience, our aim is to offer high-quality, reliable and stress-free diagnostics and therapeutic services from the comfort of our patients’ own homes.

Apheris

Seed Round in 2022
Apheris specializes in secure data sharing for machine learning. Its platform enables businesses to collaboratively analyze distributed datasets without transferring sensitive information, ensuring compliance with privacy regulations.

Entyre

Series A in 2022
Entyre is a healthcare technology company that operates an online platform to guide patients and caregivers through bureaucratic processes in the German healthcare system. Founded in 2017 and based in Hamburg, it leverages proprietary data and algorithms to collect outpatient data and support patients, physicians, and insurers in making better, more informed decisions. The platform is designed to identify and correct mismanagement in care, reduce unnecessary hospital stays, lower costs, and address opacity and complexity in the sector, with the aim of improving outcomes for individuals and the health system.

PeakData

Series A in 2022
PeakData is a software platform that identifies and analyzes key opinion leaders in specific therapeutic areas. It uses artificial intelligence to make sense of data scattered across the web.

Avi Medical

Series B in 2022
Founded in Munich, Germany in 2020, Avi Medical is a digital health company offering telemedicine services. Its platform enables patients to book appointments, manage health data, chat with practitioners, and have video consultations.

Infermedica

Series B in 2022
Infermedica, a digital health company, specializes in AI-powered preliminary diagnosis and triage solutions for insurance companies, hospitals, and health systems. Using artificial intelligence and machine learning, the company assesses symptoms, identifies patterns, and provides safe, reliable recommendations verified by a team of physicians. With over 6 million users worldwide and partnerships with over 50 companies, Infermedica aims to improve customer performance, increase healthcare accessibility, and reduce costs. Their products are available in 17 languages, including in countries like China and the United Arab Emirates. The company, with a team of over 100 people, is expanding its market presence in the United States and Europe, driven by a recent $10.25M investment.

Ceregate

Series A in 2022
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company focuses on developing a computer-brain interface (CBI) technology that enhances the programming of neuromodulation systems. This innovative platform allows for the direct transmission of information into human consciousness, utilizing existing neuromodulation implants to improve medical treatments. CereGate's technology aims to support patients with neurological disorders or sensory deficits by providing new therapeutic options that enable them to adapt and enhance their conditions independently. The company's approach encompasses a broad range of applications, from sensory substitution to gait improvement.

FORMEL Skin

Series A in 2021
Founded in Berlin, Germany in 2020, FORMEL Skin is a healthtech company specializing in personalized online dermatology. Through its platform, users can consult with licensed doctors, upload skin concerns, and receive tailored treatment plans along with recommended products.

Apriwell

Seed Round in 2021
Apriwell specializes in natural digestive supplements, focusing on chronic conditions. Their products are backed by recent scientific research and feature optimal dosages of high-quality active ingredients. Apriwell also offers a free health course with effective methods and exercises to complement their preparations.

Sanome

Pre Seed Round in 2021
Sanome develops clinical decision support software that creates a real-time digital twin of an individual's health. The platform integrates with electronic health records to analyze clinical data and deliver explainable, regulated AI-enabled tools embedded in clinical workflows, helping healthcare providers identify emerging risks earlier and make faster, more accurate decisions as part of a proactive, preventive model of care. By combining artificial intelligence with diverse data streams, including at-home biomarker tests, the system translates information into actionable insights to support early detection and improved patient outcomes.

Entyre

Pre Seed Round in 2021
Entyre is a healthcare technology company that operates an online platform to guide patients and caregivers through bureaucratic processes in the German healthcare system. Founded in 2017 and based in Hamburg, it leverages proprietary data and algorithms to collect outpatient data and support patients, physicians, and insurers in making better, more informed decisions. The platform is designed to identify and correct mismanagement in care, reduce unnecessary hospital stays, lower costs, and address opacity and complexity in the sector, with the aim of improving outcomes for individuals and the health system.

Avi Medical

Series A in 2021
Founded in Munich, Germany in 2020, Avi Medical is a digital health company offering telemedicine services. Its platform enables patients to book appointments, manage health data, chat with practitioners, and have video consultations.

LivNao

Seed Round in 2021
LivNao Technologies is a Vancouver-based company that utilizes deep learning technology to monitor and enhance mental health. By passively collecting data, LivNao's platform identifies early indicators of mental health changes before they impact performance and productivity. Once a deviation is detected, the company provides timely interventions tailored to individual health plans, promoting proactive mental health management. LivNao aims to improve the quality of life for individuals and organizations alike, enabling informed decision-making for healthcare systems and insurers. Committed to maintaining privacy and security, LivNao operates in full compliance with HIPAA regulations.

Actio

Seed Round in 2021
Actio is a Berlin-based company established in 2019 that provides a platform connecting users with professionals across a wide range of fields, including fitness, career coaching, relationships, finance, nutrition, and legal advice. The company's fitness coaching application offers live workout sessions led by professional coaches, allowing users to participate in real-time classes rather than relying on pre-recorded videos. This approach aims to enhance users' mental health by helping them manage stress and reduce anxiety while promoting overall well-being. Actio's services cater to individuals seeking personalized guidance and support in various aspects of their lives.

Avi Medical

Seed Round in 2021
Founded in Munich, Germany in 2020, Avi Medical is a digital health company offering telemedicine services. Its platform enables patients to book appointments, manage health data, chat with practitioners, and have video consultations.

Moray Medical

Seed Round in 2021
Moray Medical is a company focused on developing innovative robotic delivery systems for structural heart therapies, specifically targeting edge-to-edge valve leaflet repair. The company aims to enhance the quality of life for millions affected by leaky heart valves by providing cardiologists with advanced tools for mitral valve clip therapies. Moray Medical's proprietary microfluidic robotics technology enables the precise and safe delivery of treatments, utilizing a compact, reusable fluid-drive system that features a digital interface for maneuvering flexible delivery catheters with ease, akin to using a computer cursor. This approach allows for cost-effective interventions, making life-saving heart valve therapies more accessible to a broader range of patients in need.

Ceregate

Series A in 2020
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company focuses on developing a computer-brain interface (CBI) technology that enhances the programming of neuromodulation systems. This innovative platform allows for the direct transmission of information into human consciousness, utilizing existing neuromodulation implants to improve medical treatments. CereGate's technology aims to support patients with neurological disorders or sensory deficits by providing new therapeutic options that enable them to adapt and enhance their conditions independently. The company's approach encompasses a broad range of applications, from sensory substitution to gait improvement.

Infermedica

Series A in 2020
Infermedica, a digital health company, specializes in AI-powered preliminary diagnosis and triage solutions for insurance companies, hospitals, and health systems. Using artificial intelligence and machine learning, the company assesses symptoms, identifies patterns, and provides safe, reliable recommendations verified by a team of physicians. With over 6 million users worldwide and partnerships with over 50 companies, Infermedica aims to improve customer performance, increase healthcare accessibility, and reduce costs. Their products are available in 17 languages, including in countries like China and the United Arab Emirates. The company, with a team of over 100 people, is expanding its market presence in the United States and Europe, driven by a recent $10.25M investment.

Siilo

Series A in 2020
Siilo is a secure medical messaging platform for healthcare teams that facilitates clinical collaboration, workflow management, and peer discussion to improve patient care. The app supports messaging, video calling, and a web interface, and is designed to keep personal and professional data separate on devices while storing patient information in an encrypted vault to protect privacy. Founded in 2016 and based in Amsterdam, Siilo serves physicians, nurses, and other healthcare staff, enabling secure communication and collaboration across care teams while aiming to enhance outcomes and efficiency.

Actio

Seed Round in 2020
Actio is a Berlin-based company established in 2019 that provides a platform connecting users with professionals across a wide range of fields, including fitness, career coaching, relationships, finance, nutrition, and legal advice. The company's fitness coaching application offers live workout sessions led by professional coaches, allowing users to participate in real-time classes rather than relying on pre-recorded videos. This approach aims to enhance users' mental health by helping them manage stress and reduce anxiety while promoting overall well-being. Actio's services cater to individuals seeking personalized guidance and support in various aspects of their lives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.